focus -WSS

focus

author：explore 2025-08-12 09:12:56 - browse：73

John Crowley pictured with his daughter Megan Crowley — health policy news from STAT — John Crowley pictured with his daughter Megan. Crowley family

WASHINGTON — The Biotechnology Innovation Organization has chosen longtime biotech executive and rare disease advocate John Crowley as its new CEO, the organization announced Tuesday.

Crowley came to biotech when his children were diagnosed with a rare genetic neuromuscular disease. He started working at Bristol Myers Squibb, and started Novazyme, which was eventually successful in creating an enzyme replacement therapy for Pompe disease. He later started and worked for several different biotech companies, most recently with Amicus Therapeutics, which had a drug approved to treat the disease in September.

The trade association’s board chair, Ted Love, served on the board of the company.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Bernie Sanders gets little from pharma CEOs on drug prices

WSS

AstraZeneca to buy developer of next

Congress must protect the remaining independent doctors

Latigo launches with $135 million for Vertex

Websites selling Wegovy, Zepbound ingredients targeted by FDA

Eli Lilly reports tirzepatide MASH success during Q4 earnings

Methadone treatment changes are coming. Do they go far enough?

focus

focus

focus

Wildfire smoke exposes gaps in outdoor worker protections

Colonoscopy prep: Liquid

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Nurses recount patients attacks

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Artificial intelligence use in health care faces greater scrutiny in 2024

Heart attack and stroke risk calculators need revising

Study gives hint on South Asians’ higher risk of cardiovascular disease

Jerome Adams on the need for new antivirals for Covid

CVS Caremark has created a new ploy: the drug ‘rebate credit’

knowledge

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Abbott's new heart device gets FDA advisory panel nod

AMAs digital advisors table RPM coding reform proposal, again

Baby aspirin cuts fat buildup in liver disease patients, in small study

Study gives hint on South Asians’ higher risk of cardiovascular disease

AstraZeneca to buy developer of next

leisure time

entertainment

Wikipedia

entertainment